

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
AEMD
Aethlon Medical Inc.
$5.43
 Login to see Aethlon Medical Inc. (AEMD)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see Aethlon Medical Inc. (AEMD)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths

Earnings are forecast to grow

Trading below its fair value
Chart
$0.8 (+578.75%)
$1.18 (+360.17%)
$1.99 (+172.86%)
$0.4 (+1257.50%)
AEMD has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

 
AEMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

AEMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
AEMD Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
 Login to display
  Login to displayAEMD Earnings
The TTM reflects 12-month period, providing review of AEMD financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is AEMD current stock price?
What are AEMD stock strengths?
What risks are associated with AEMD stock?
When is AEMD next earnings report?
What is AEMD market cap and volume?
What is AEMD's current Stock IQ?
Should I buy AEMD stock right now?
Is AEMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for AEMD?
What does a 'Strong Sell' rating mean for AEMD?
What factors influence AEMD's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
AEMD
Aethlon Medical Inc.
Current Price
$5.43
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value
 Login to unlock Aethlon Medical Inc. (AEMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to unlock Aethlon Medical Inc. (AEMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid  
Chart
$0.8 (+578.75%)
$1.18 (+360.17%)
$1.99 (+172.86%)
$0.4 (+1257.50%)
AEMD Analysts Opinion
 
AEMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

AEMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
AEMD Street view is extremely bullish and have positive views on the near-term outlook
AEMD has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

Average key support and resistance price levels.
 Login to display
  Login to displayAEMD Earnings
The TTM data reflects the most recent 12-month period, providing overview of AEMD financial performance.
AEMD Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
AEMD Latest Analysis
AEMD: Early Oncology Trial Data Looks Promising . By Cohort 1 preliminary data looks promising regarding Hemopurifiers potential as an oncology treatment but it is early in the studyAethlon Medical (NASDAQ:AEMD) is conducting a basket oncology trial to study the impact of the Hemopurifier® therapeutic blood filtration system as a potential treatment in patients with various solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. Unfortunately only about 30% of
Tue Oct 21, 2025
AEMD: Oncology Trial Advances as Early Data Looks Promising . By Cohort 1 preliminary data looks promising regarding Hemopurifiers potential as an oncology treatment but it is early in the studyAethlon Medical (NASDAQ:AEMD) is conducting a basket oncology trial to study the impact of the Hemopurifier® therapeutic blood filtration system as a potential treatment in patients with various solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. Unfortunately only
Fri Oct 10, 2025
 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AEMD Stock trends
AEMD Stock performance
AEMD Stock analysis
AEMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.